Showing results (571-580 of 587) with videos related to

Sort By:
Pageof 59
JAMA Network Open|February 22, 2024
Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical TrialThomas J Stopka, Denise C Babineau, Erin B Gibson, et al.
Communications Medicine|February 28, 2024
Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalizationAndrew J Morrow, Robert Sykes, Merna Saleh, et al.
Nature Medicine|May 23, 2022
A multisystem, cardio-renal investigation of post-COVID-19 illnessAndrew J Morrow, Robert Sykes, Alasdair McIntosh, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Nanopore sequencing of 1000 Genomes Project samples to build a comprehensive catalog of human genetic variationJonas A Gustafson, Sophia B Gibson, Nikhita Damaraju, et al.
Genome Research|October 2, 2024
High-coverage nanopore sequencing of samples from the 1000 Genomes Project to build a comprehensive catalog of human genetic variationJonas A Gustafson, Sophia B Gibson, Nikhita Damaraju, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 EpisignatureChristy W LaFlamme, Cassandra Rastin, Soham Sengupta, et al.
Genome Medicine|March 27, 2019
Correction to: De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndromeFrancesco Vetrini, Shane McKee, Jill A Rosenfeld, et al.
American Journal of Human Genetics|January 31, 2017
De Novo Disruption of the Proteasome Regulatory Subunit PSMD12 Causes a Syndromic Neurodevelopmental DisorderSébastien Küry, Thomas Besnard, Frédéric Ebstein, et al.
Genome Medicine|March 2, 2019
De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndromeFrancesco Vetrini, Shane McKee, Jill A Rosenfeld, et al.
Nature Communications|August 6, 2024
Diagnostic utility of DNA methylation analysis in genetically unsolved pediatric epilepsies and CHD2 episignature refinementChristy W LaFlamme, Cassandra Rastin, Soham Sengupta, et al.
Pageof 59